Shengdi Su

Evaluation of a Clinically Relevant Drug–Drug Interaction Between Rosuvastatin and Clopidogrel and the Risk of Hepatotoxicity

Xijing Chen, H. Xing, Jiake He, 2021, Frontiers in Pharmacology.

Protective Effects of Mitochondrial Uncoupling Protein 2 against Aristolochic Acid I-Induced Toxicity in HK-2 Cells

F. Yu, Shengdi Su, Etienne Empweb Anger, 2022, International journal of molecular sciences.

Self-assembling Branched Amphiphilic Peptides for Targeted Delivery of Small Molecule Anticancer Drugs.

Chengzhi He, Long Chen, S. Luo, 2022, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Characterization of Preclinical Pharmacokinetic Properties and Prediction of Human PK Using a Physiologically Based Pharmacokinetic Model for a Novel Anti-Arrhythmic Agent Sulcardine Sulfate

Xijing Chen, Yongjie Zhang, Ning Li, 2021, Pharmaceutical Research.

An investigation on nephrotoxicity of Aristolactam I induced epithelial-mesenchymal transition on HK-2 cells.

Shuxin Zhao, F. Yu, Shengdi Su, 2021, Toxicon : official journal of the International Society on Toxinology.

Development and validation of a chiral UPLC-MS/MS method for quantifying S-Oxiracetam and R-Oxiracetam in human plasma, urine and feces: Application to a phase-I clinical pharmacokinetic study.

Shengdi Su, Xijing Chen, Lu-Jing Han, 2023, Journal of pharmaceutical and biomedical analysis.